4.

Multivariate analysis of baseline factors associated with selection of docetaxel/anthracycline combination

Factor	Odds ratio	95% CI	P
95% CI, 95% confidence interval; *, upper limit of 95% CI is 1.000 due to rounding.
Age group (year)
40–<65vs. <40	0.887	(0.708, 1.112)	0.298
≥65 vs. <40	0.463	(0.305, 0.703)	<0.001
Weight (kg)	0.991	(0.981, 1.000*)	0.049
Menopausal status
Peri-menopause vs. pre-menopause	0.573	(0.301, 1.092)	0.091
Post-menopause vs. pre-menopause	0.712	(0.602, 0.842)	<0.001
Estrogen receptor
Positive vs. negative	1.112	(0.948, 1.305)	0.192
Unknown vs. negative	2.261	(1.279, 3.998)	0.005
Tumor type
Lobular carcinoma vs. ductal carcinoma	2.868	(1.822, 4.515)	<0.001
Medullary carcinoma vs. ductal carcinoma	1.276	(0.429, 3.792)	0.661
Mixed carcinoma vs. ductal carcinoma	0.969	(0.487, 1.926)	0.928
Mucinous carcinoma vs. ductal carcinoma	1.340	(0.399, 4.499)	0.636
Tubular carcinoma vs. ductal carcinoma	0.733	(0.183, 2.940)	0.661
Other vs. ductal carcinoma	1.294	(0.903, 1.853)	0.160
Unknown vs. ductal carcinoma	0.785	(0.556, 1.108)	0.169